First trimester screening for Preeclampsia (PE) using FMF-London-Algorithm with placenta associated plasma protein-a (PAPP-A) and placental growth factor (PlGF)
C Birdir, A Enekwe, A Iannaccone, J Fryze, A Gellhaus, A Köninger, R Kimmig · Ultraschall in der Medizin - European Journal of Ultrasound · 2016 · Heft 08
Bibliografische Angaben
Zusammenfassung
Purpose: To investigate the pregnancy outcomes of the high risk population after screening and off-label use of acetylsalicylic acid (ASA) 100 mg/day. Materials and methods: 343 patients were screened between August 2013 and August 2015 using the FMF-London-Software combining the maternal history with multiple of the median (MoM) – Results of PlGF, PAPP-A, mean arterial pressure and pulsaltiliy index of uterine arteries. Results: 40 patients (12%) were screened positive for early-onset PE with a cut-off of 1:150. 26 patients (84%) accepted a prophylactic off-label therapy with ASA 100 mg/day. Among these patient…
